. Author manuscript; available in PMC: 2020 May 1.

Published in final edited form as: Gynecol Oncol. 2019 Mar 1;153(2):266–270. doi: 10.1016/j.ygyno.2019.02.024

Table 2:

Anal Cytology and Anal HPV 16/18 testing by disease site

	All^a	Cervix	Vagina	Vulva	p-value
Total	75	48	13	17
Anal cytology results, n (%)					0.01
Normal	59 (78.7)	42 (87.5)	9 (69.2)	9 (52.9)
Abnormal	16 (21.3)	6 (12.5)	4 (30.8)	8 (47.1)
Abnormal anal cytology results, n (%)					0.86
ASCUS	12 (75.0)	5 (83.3)	3 (75.0)	5 (62.5)
LSIL	2 (12.5)	0 (0.0)	1 (25.0)	2 (25.0)
HSIL	2 (12.5)	1 (16.7)	0 (0.0)	1 (12.5)
Anal HPV 16/18 testing results, n (%)					0.21
Positive	15 (20.0)	9 (18.7)	1 (7.7)	6 (35.3)
Negative	48 (64.0)	33 (68.8)	8 (61.5)	8 (47.1)
Insufficient	12 (16.0)	6 (12.5)	4 (30.8)	3 (17.6)

: one patient with cervical disease and two patients with vulva disease also presented with vaginal disease

ASCUS: atypical squamous cells of undetermined significance; LSIL: low-grade squamous intraepithelial lesion; HSIL: high-grade squamous intraepithelial lesion